ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-3H14403
Home | Market Reports | Health| Health Conditions| Cancer
Global Vascular Endothelial Growth Factor VEGF Inhibitors Market Research Report 2023
BUY CHAPTERS

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Insights, Forecast to 2030

Code: QYRE-Auto-3H14403
Report
December 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
F Hoffmann La Roche Ltd
Novartis
Regeneron Pharmaceuticals Inc
Sanofi

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market

Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels.
Market Analysis and Insights: Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
The global Vascular Endothelial Growth Factor (VEGF) Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Vascular Endothelial Growth Factor (VEGF) Inhibitors market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Vascular Endothelial Growth Factor (VEGF) Inhibitors, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Vascular Endothelial Growth Factor (VEGF) Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vascular Endothelial Growth Factor (VEGF) Inhibitors revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Vascular Endothelial Growth Factor (VEGF) Inhibitors revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Report

Report Metric Details
Report Name Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • VEGF-A Inhibitor
  • VEGF-B Inhibitor
  • VEGF-C Inhibitor
  • VEGF-D Inhibitor
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Sanofi.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Vascular Endothelial Growth Factor (VEGF) Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Vascular Endothelial Growth Factor (VEGF) Inhibitors companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vascular Endothelial Growth Factor (VEGF) Inhibitors revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Vascular Endothelial Growth Factor (VEGF) Inhibitors Market report?

Ans: The main players in the Vascular Endothelial Growth Factor (VEGF) Inhibitors Market are Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Sanofi.

What are the Application segmentation covered in the Vascular Endothelial Growth Factor (VEGF) Inhibitors Market report?

Ans: The Applications covered in the Vascular Endothelial Growth Factor (VEGF) Inhibitors Market report are Oncology, Ophthalmology

What are the Type segmentation covered in the Vascular Endothelial Growth Factor (VEGF) Inhibitors Market report?

Ans: The Types covered in the Vascular Endothelial Growth Factor (VEGF) Inhibitors Market report are VEGF-A Inhibitor, VEGF-B Inhibitor, VEGF-C Inhibitor, VEGF-D Inhibitor

Recommended Reports

Vascular Devices

VEGF Inhibitors

Cardiovascular Segment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 VEGF-A Inhibitor
1.2.3 VEGF-B Inhibitor
1.2.4 VEGF-C Inhibitor
1.2.5 VEGF-D Inhibitor
1.3 Market by Application
1.3.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Ophthalmology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Perspective (2019-2030)
2.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Trends by Region
2.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size by Region (2019-2024)
2.2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Region (2025-2030)
2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Dynamics
2.3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Trends
2.3.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Drivers
2.3.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Challenges
2.3.4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Vascular Endothelial Growth Factor (VEGF) Inhibitors by Players
3.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Players (2019-2024)
3.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Players (2019-2024)
3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Vascular Endothelial Growth Factor (VEGF) Inhibitors, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Concentration Ratio
3.4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue in 2023
3.5 Global Key Players of Vascular Endothelial Growth Factor (VEGF) Inhibitors Head office and Area Served
3.6 Global Key Players of Vascular Endothelial Growth Factor (VEGF) Inhibitors, Product and Application
3.7 Global Key Players of Vascular Endothelial Growth Factor (VEGF) Inhibitors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Breakdown Data by Type
4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size by Type (2019-2024)
4.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Type (2025-2030)
5 Vascular Endothelial Growth Factor (VEGF) Inhibitors Breakdown Data by Application
5.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size by Application (2019-2024)
5.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2019-2030)
6.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
6.2.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024)
6.2.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030)
6.2.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
6.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
6.3.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024)
6.3.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030)
6.3.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
6.4 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
6.4.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024)
6.4.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2019-2030)
7.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
7.2.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024)
7.2.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030)
7.2.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
7.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
7.3.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024)
7.3.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030)
7.3.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
7.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
7.4.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024)
7.4.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2019-2030)
8.2 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
8.2.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024)
8.2.2 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030)
8.2.3 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
8.3 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
8.3.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024)
8.3.2 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030)
8.3.3 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2019-2030)
9.2 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
9.2.1 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024)
9.2.2 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030)
9.2.3 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
9.3 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
9.3.1 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024)
9.3.2 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030)
9.3.3 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
9.4 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region
9.4.1 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2019-2024)
9.4.3 Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
10.2.1 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
10.3.1 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
10.4.1 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.1.4 Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
11.1.5 Bayer AG Recent Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Details
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.3.4 Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
11.3.5 Novartis AG Recent Developments
11.4 Regeneron Pharmaceuticals Inc.
11.4.1 Regeneron Pharmaceuticals Inc. Company Details
11.4.2 Regeneron Pharmaceuticals Inc. Business Overview
11.4.3 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.4.4 Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
11.4.5 Regeneron Pharmaceuticals Inc. Recent Developments
11.5 Sanofi.
11.5.1 Sanofi. Company Details
11.5.2 Sanofi. Business Overview
11.5.3 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.5.4 Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
11.5.5 Sanofi. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Bayer
F Hoffmann La Roche Ltd
Novartis
Regeneron Pharmaceuticals Inc
Sanofi
List of Tables
    Table 1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of VEGF-A Inhibitor
    Table 3. Key Players of VEGF-B Inhibitor
    Table 4. Key Players of VEGF-C Inhibitor
    Table 5. Key Players of VEGF-D Inhibitor
    Table 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2019-2024)
    Table 10. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2025-2030)
    Table 12. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Trends
    Table 13. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Drivers
    Table 14. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Challenges
    Table 15. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Restraints
    Table 16. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Share by Players (2019-2024)
    Table 18. Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors as of 2023)
    Table 19. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Vascular Endothelial Growth Factor (VEGF) Inhibitors, Headquarters and Area Served
    Table 22. Global Key Players of Vascular Endothelial Growth Factor (VEGF) Inhibitors, Product and Application
    Table 23. Global Key Players of Vascular Endothelial Growth Factor (VEGF) Inhibitors, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2019-2024)
    Table 27. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2025-2030)
    Table 29. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Share by Application (2019-2024)
    Table 31. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Share by Application (2025-2030)
    Table 33. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Bayer AG Company Details
    Table 66. Bayer AG Business Overview
    Table 67. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
    Table 68. Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
    Table 69. Bayer AG Recent Developments
    Table 70. F. Hoffmann-La Roche Ltd. Company Details
    Table 71. F. Hoffmann-La Roche Ltd. Business Overview
    Table 72. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
    Table 73. F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
    Table 74. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 75. Novartis AG Company Details
    Table 76. Novartis AG Business Overview
    Table 77. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
    Table 78. Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
    Table 79. Novartis AG Recent Developments
    Table 80. Regeneron Pharmaceuticals Inc. Company Details
    Table 81. Regeneron Pharmaceuticals Inc. Business Overview
    Table 82. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
    Table 83. Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
    Table 84. Regeneron Pharmaceuticals Inc. Recent Developments
    Table 85. Sanofi. Company Details
    Table 86. Sanofi. Business Overview
    Table 87. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
    Table 88. Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
    Table 89. Sanofi. Recent Developments
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type: 2023 VS 2030
    Figure 3. VEGF-A Inhibitor Features
    Figure 4. VEGF-B Inhibitor Features
    Figure 5. VEGF-C Inhibitor Features
    Figure 6. VEGF-D Inhibitor Features
    Figure 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application: 2023 VS 2030
    Figure 9. Oncology Case Studies
    Figure 10. Ophthalmology Case Studies
    Figure 11. Vascular Endothelial Growth Factor (VEGF) Inhibitors Report Years Considered
    Figure 12. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region: 2023 VS 2030
    Figure 15. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Players in 2023
    Figure 16. Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue in 2023
    Figure 18. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
    Figure 20. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
    Figure 21. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2019-2030)
    Figure 22. United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
    Figure 26. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
    Figure 27. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2019-2030)
    Figure 28. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
    Figure 36. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
    Figure 37. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
    Figure 39. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
    Figure 40. Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2019-2030)
    Figure 41. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2019-2030)
    Figure 51. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Bayer AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
    Figure 58. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
    Figure 59. Novartis AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
    Figure 60. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
    Figure 61. Sanofi. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global VEGF Inhibitors Market Research Report 2024
VEGF Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global VEGF Inhibitors for Cancer Market Research Report 2024
Global Anti Vascular Endothelial Growth Factor Therapeutic Market Research Report 2025
Global VEGF A Inhibitor Market Research Report 2024
Global Anti VEGF Drugs for Angiogenesis related Disease Market Research Report 2024
Vascular Endothelial Growth Factor Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti VEGF Therapeutic Market Research Report 2025
Global VEGFR 2 Inhibitor Market Research Report 2024
Global Anti VEGT Drugs Market Research Report 2024
Global Anti VEGF Therapy for Cancer Market Research Report 2024
Anti vascular Endothelial Growth Factor Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Angiogenesis Inhibitors Market Research Report 2024
Global Fusion Protein VEGF Inhibitor Market Research Report 2024
Global Monoclonal Antibody VEGF Inhibitors Market Research Report 2024
Global Anti VEGF Ophthalmic Drugs Market Research Report 2024
Anti VEGF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vascular Endothelial Growth Factor VEGF Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Angiogenesis Therapeutic Agent Market Research Report 2024
Anti vascular Endothelial Growth Factor Anti VEGF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions